Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developing a global strategy for cancer.

K Sikora1

  • 1World Health Organisation Cancer Programme, International Agency for Research on Cancer, Lyon, France. sikora@iarc.fr

European Journal of Cancer (Oxford, England : 1990)
|March 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COX2 Effects on endometrial carcinomas progression.

Pathology, research and practice·2022
Same author

How Useful is COVID-19 Antibody Testing - A Current Assessment for Oncologists.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

The Road Map for Proton Therapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2018
Same author

Heavy metals effect on breast cancer progression.

Journal of occupational medicine and toxicology (London, England)·2017
Same author

RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2011
Same author

The independent sector and advanced radiotherapy technology.

Clinical oncology (Royal College of Radiologists (Great Britain))·2010
Same journal

Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

European journal of cancer (Oxford, England : 1990)·2026
See all related articles

Cancer incidence is projected to double by 2020. Technological advances in genomics and imaging offer new detection and treatment strategies, but equitable access remains a challenge.

Area of Science:

  • Oncology
  • Genomics
  • Medical Technology

Background:

  • Global cancer incidence is rising dramatically, projected to reach 20 million by 2020.
  • Despite significant research investment, a definitive cure for cancer remains elusive.
  • The public increasingly fears cancer, highlighting the need for advanced solutions.

Purpose of the Study:

  • To explore the impact of emerging technologies on cancer detection and treatment.
  • To discuss the societal and healthcare system implications of these advancements.
  • To address the potential for widening global health disparities due to technological access.

Main Methods:

  • Advancements in medical imaging for painless, detailed body visualization.
  • Human genome sequencing to understand genetic factors in cancer.

Related Experiment Videos

  • Development of gene chips for detecting genetic mutations.
  • Novel screening technologies for early cancer cell detection.
  • Robotically guided therapies for targeted cancer cell destruction.

    • Main Results:

    • The human genome sequence will be fully determined by 2003.
    • Computer networks will facilitate genetic comparisons and risk factor identification.
    • Gene chips will identify relevant genetic code changes.
    • Early cancer detection and targeted treatment before symptom onset are anticipated.
    • Increased public access to health information and understanding of medical choices.

    Conclusions:

    • Technological progress promises significant improvements in cancer care.
    • Public education is crucial for informed health decisions and realistic media assessment.
    • The gap between global rich and poor may widen, disproportionately affecting developing nations.
    • Unhealthy lifestyles contribute to rising cancer rates in developing countries.
    • The WHO Cancer Programme is developing strategies for global cancer control.